Clinico-Pathology of Newly Diagnosed Breast Cancer With Expression of ER, PR, and HER/2neu in Cell Blocks: An Observational Prospective Study

F1000Research - United Kingdom
doi 10.12688/f1000research.19963.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Prediction of Tumor Mutation Burden in Breast Cancer Based on the Expression of ER, PR, HER-2, and Ki-67

OncoTargets and Therapy
OncologyPharmacology
2018English

A Study on the Role of Receptor (ER,PR,HER-2/neu) in Patients of Carcinoma Breast

International Journal Of Medical Science And Clinical Invention
2017English

Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Study on Histopathological Correlation With ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and Its Prognostic Importance

SSR Institute of International Journal of Life Sciences
2019English

Fatigue and Herpesvirus Latency in Women Newly Diagnosed With Breast Cancer

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2012English

Return to Work After Breast Cancer Diagnosis: An Observational Prospective Study in Brazil

Cancer
Cancer ResearchOncology
2018English

A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Factors Associated With Advanced Disease Stage at Diagnosis in a Study of Patients With Newly Diagnosed Breast Cancer

Journal of Cancer Treatment and Research
2018English

SS8 Active Surveillance for Men With Newly Diagnosed Prostate Cancer : Critical Role of Pathology

Japanese Journal of Urology
Urology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy